CASI Pharmaceuticals, Inc. (41) | Business Finance (12)

Browse by Subcategory

Recent Contracts

Promissory Note issued by the Registrant to East West Bank, dated May 23, 2022 (Filed With SEC on August 12, 2022)
Business Loan Agreement between the Registrant and East West Bank, dated May 23, 2022 (Filed With SEC on August 12, 2022)
Commercial Security Agreement between the Registrant and East West Bank, dated May 23, 2022 (Filed With SEC on August 12, 2022)
Commercial Pledge Agreement between the Registrant and East West Bank, dated May 23, 2022 (Filed With SEC on August 12, 2022)
Common Stock Sales Agreement (the Sales Agreement) by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated October 29, 2021 (Filed With SEC on October 29, 2021)
Investment Agreement by and between Juventas Cell Therapy Ltd and CASI Biopharmaceuticals (WUXI) Co., Ltd. effective as of September 22, 2020 (Filed With SEC on November 9, 2020)
Contract for Assignment of the Right to the Use of the State-owned Construction Land (no. 3202842019CR0019) dated November 15, 2019 (Filed With SEC on March 16, 2020)
Description of Common Stock (Filed With SEC on March 30, 2021)
Description of Common Stock (Filed With SEC on March 16, 2020)
Investment Agreement in respect of Juventas Cell Therapy Ltd. executed June 15, 2019 (Filed With SEC on August 9, 2019)
Amendment No. 1 to Common Stock Sales Agreement by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated July 19, 2019 (Filed With SEC on July 19, 2019)
Shareholders Agreement, dated November 16, 2018, between CASI Pharmaceuticals, Inc. and Wuxi Jintou Huicun Investment Enterprise (Limited Partnership) (Filed With SEC on March 29, 2019)